Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Tumefactive multiple sclerosis lesions under fingolimod treatment.
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection-a case report.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on Natalizumab.
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
Multiple sclerosis.
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
Treatment of multiple sclerosis with anti-CD20 antibodies.
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
A comparative study of experimental mouse models of central nervous system demyelination.
T cells become licensed in the lung to enter the central nervous system.
Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
Galectin-1 for neuroprotection?
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment.

Pages